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Genome-wide associated studies have provided a first
understanding of the genetics behind breast and prostate
cancer risk. However, this methodology has limitations
in that only previously detected variants can be interro-
gated, and thus it also is limited to variants with high
frequency in a population. Genetic variants detected by
genome-wide associated studies each commonly have a
low impact on the risk of developing disease. Addition-
ally, a handful of genes have been detected to confer a
moderate risk of developing disease.
With the advent of exome sequencing of the genome
of various tumor types, it is becoming clear that very
few somatically mutated genes (SMGs) are limited to a
single tumor type, but rather that most SMGs are found
in several tumor types, albeit in different frequencies.
Here we outline a project aimed at investigating germ-
line variation in 1,242 genes known to be somatically
mutated in various cancer types, and their association to
the risk of breast and prostate cancer.
We have previously developed a methodology to per-
form a library preparation for sequencing, from genomic
DNA to ligated adapters, in a single tube without purifica-
tion steps (Neiman et al. 2012, submitted). Here we modi-
fied this protocol to a 96-plate format by ligating a specific
barcode in each well in the plate, prior to pooling of wells
in batches of 48 samples. This was followed by a sequence
capture of the targeted 1,242 genes of interest.
Based on previously collected sample sets where exten-
sive questionnaire data are available for lifestyle factors,
family history of cancer et cetera, we selected 480 breast
cancer cases and 480 prostate cancer cases with a positive
family history and/or young age of onset. Controls for the
prostate cancer set were selected to be cancer-free, have a
prostate specific antigen of < 1 ng/ml above the age of
56 years. For breast cancer, controls were selected to be
cancer-free over the age of 68 years. This extreme design
in case/control selection is aimed at enriching for genetic
markers of intermediate penetrance for risk of breast and/
or prostate cancer in this discovery step of the study.
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